http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8048019-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7317808024e524eea40a6c5a5ad6a22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-30
filingDate 2007-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2def70257dbbee4476890697860cb1cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4b7e8b5ff6ec51ed9fc9a48f40143bd
publicationDate 2011-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8048019-B2
titleOfInvention Multiple nozzle transdermal drug delivery system
abstract A transdermal drug delivery system ( 100 ) for providing controlled doses of a drug through the skin of a human or other animal is disclosed. In one embodiment, the transdermal drug delivery system ( 100 ) includes a substrate ( 110 ) designed to adhere to skin and a transdermal injector array ( 140 ) coupled to the substrate ( 110 ). The transdermal array ( 140 ) has one or more transdermal injectors ( 210, 220, 230 ) embedded within including a first transdermal injector ( 210 ) configured to administer or provide a first substance to the skin at a speed great enough to produce an appreciable breach in the surface of the skin.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110272-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10052468-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9566431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10912934-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510602-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11452474-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013084189-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9144434-B1
priorityDate 2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006086742-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006184101-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004012795-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006216337-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39338
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751

Total number of triples: 33.